

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | signal peptide processing (GO:0006465) | 6.11386489 |
| 2 | proteasome assembly (GO:0043248) | 6.01080084 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.96392569 |
| 4 | COPI coating of Golgi vesicle (GO:0048205) | 4.96392569 |
| 5 | fatty acid elongation (GO:0030497) | 4.44089898 |
| 6 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.28783126 |
| 7 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.25687299 |
| 8 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.25206653 |
| 9 | central nervous system myelination (GO:0022010) | 4.19884301 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 4.19884301 |
| 11 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.10773127 |
| 12 | respiratory chain complex IV assembly (GO:0008535) | 4.03394424 |
| 13 | lactate metabolic process (GO:0006089) | 4.01929121 |
| 14 | protein maturation by protein folding (GO:0022417) | 3.99345019 |
| 15 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.99188110 |
| 16 | cullin deneddylation (GO:0010388) | 3.98620949 |
| 17 | ER overload response (GO:0006983) | 3.94561138 |
| 18 | negative regulation of ligase activity (GO:0051352) | 3.87657819 |
| 19 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.87657819 |
| 20 | cytochrome complex assembly (GO:0017004) | 3.80963869 |
| 21 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.78761331 |
| 22 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.77843523 |
| 23 | protein deneddylation (GO:0000338) | 3.77794760 |
| 24 | nucleotide transmembrane transport (GO:1901679) | 3.69770371 |
| 25 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.67843077 |
| 26 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.67843077 |
| 27 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.67668825 |
| 28 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.67586741 |
| 29 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.67586741 |
| 30 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.67586741 |
| 31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.59990550 |
| 32 | L-phenylalanine catabolic process (GO:0006559) | 3.59990550 |
| 33 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.54277213 |
| 34 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.47803415 |
| 35 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.47803415 |
| 36 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.47787363 |
| 37 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.47560975 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.46341067 |
| 39 | positive regulation of ligase activity (GO:0051351) | 3.42214031 |
| 40 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.40995465 |
| 41 | peptidyl-histidine modification (GO:0018202) | 3.39906586 |
| 42 | positive regulation of actin filament depolymerization (GO:0030836) | 3.34141683 |
| 43 | branched-chain amino acid catabolic process (GO:0009083) | 3.33150402 |
| 44 | ribosome assembly (GO:0042255) | 3.32434551 |
| 45 | peptide hormone processing (GO:0016486) | 3.31684273 |
| 46 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.29082774 |
| 47 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.28847097 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.26095800 |
| 49 | C-terminal protein lipidation (GO:0006501) | 3.25058636 |
| 50 | regulation of mitochondrial translation (GO:0070129) | 3.18818771 |
| 51 | platelet dense granule organization (GO:0060155) | 3.18183392 |
| 52 | chaperone-mediated protein transport (GO:0072321) | 3.16422572 |
| 53 | phagosome maturation (GO:0090382) | 3.16006437 |
| 54 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.15035630 |
| 55 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.15035630 |
| 56 | protein retention in ER lumen (GO:0006621) | 3.11138929 |
| 57 | pH reduction (GO:0045851) | 3.10830575 |
| 58 | regulation of cellular amine metabolic process (GO:0033238) | 3.08044568 |
| 59 | inner mitochondrial membrane organization (GO:0007007) | 3.07413475 |
| 60 | magnesium ion transport (GO:0015693) | 3.05738310 |
| 61 | protein heterotetramerization (GO:0051290) | 3.04519504 |
| 62 | L-phenylalanine metabolic process (GO:0006558) | 3.03410680 |
| 63 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.03410680 |
| 64 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.03305542 |
| 65 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.02747196 |
| 66 | C-terminal protein amino acid modification (GO:0018410) | 3.01487911 |
| 67 | neutrophil activation involved in immune response (GO:0002283) | 2.99711792 |
| 68 | transferrin transport (GO:0033572) | 2.98103971 |
| 69 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.97292596 |
| 70 | regulation of ligase activity (GO:0051340) | 2.95428054 |
| 71 | intracellular pH reduction (GO:0051452) | 2.95140417 |
| 72 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.92010981 |
| 73 | regulation of metalloenzyme activity (GO:0048552) | 2.91989364 |
| 74 | positive regulation of cell cycle arrest (GO:0071158) | 2.91750834 |
| 75 | COPII vesicle coating (GO:0048208) | 2.90652019 |
| 76 | positive regulation of protein autophosphorylation (GO:0031954) | 2.90198674 |
| 77 | negative regulation of protein ubiquitination (GO:0031397) | 2.89855905 |
| 78 | respiratory electron transport chain (GO:0022904) | 2.89210713 |
| 79 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.87165412 |
| 80 | protein neddylation (GO:0045116) | 2.85701816 |
| 81 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.85402187 |
| 82 | establishment of integrated proviral latency (GO:0075713) | 2.84828922 |
| 83 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.84583174 |
| 84 | ATP synthesis coupled proton transport (GO:0015986) | 2.84299314 |
| 85 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.84299314 |
| 86 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.83512890 |
| 87 | ferric iron transport (GO:0015682) | 2.82939323 |
| 88 | trivalent inorganic cation transport (GO:0072512) | 2.82939323 |
| 89 | lipid particle organization (GO:0034389) | 2.81415407 |
| 90 | electron transport chain (GO:0022900) | 2.81355399 |
| 91 | aldehyde catabolic process (GO:0046185) | 2.79559490 |
| 92 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.79237713 |
| 93 | negative regulation of neurotransmitter transport (GO:0051589) | 2.79018590 |
| 94 | sequestering of metal ion (GO:0051238) | 2.78520496 |
| 95 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.78459206 |
| 96 | xenobiotic catabolic process (GO:0042178) | 2.76974636 |
| 97 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.76143258 |
| 98 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.76143258 |
| 99 | regulation of glucokinase activity (GO:0033131) | 2.73802488 |
| 100 | regulation of hexokinase activity (GO:1903299) | 2.73802488 |
| 101 | cholesterol biosynthetic process (GO:0006695) | 2.72887078 |
| 102 | protein K11-linked ubiquitination (GO:0070979) | 2.71296497 |
| 103 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.70883111 |
| 104 | mannosylation (GO:0097502) | 2.70325128 |
| 105 | rRNA modification (GO:0000154) | 2.67824324 |
| 106 | angiotensin maturation (GO:0002003) | 2.66423906 |
| 107 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.65769962 |
| 108 | peptide metabolic process (GO:0006518) | 2.64920798 |
| 109 | exocrine pancreas development (GO:0031017) | 2.63793307 |
| 110 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.62735135 |
| 111 | DNA double-strand break processing (GO:0000729) | 2.61747908 |
| 112 | endocrine pancreas development (GO:0031018) | 2.61380205 |
| 113 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60250502 |
| 114 | membrane budding (GO:0006900) | 2.58959628 |
| 115 | amyloid precursor protein metabolic process (GO:0042982) | 2.58921921 |
| 116 | glycerol ether metabolic process (GO:0006662) | 2.58604488 |
| 117 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.57491951 |
| 118 | L-methionine salvage (GO:0071267) | 2.57466538 |
| 119 | L-methionine biosynthetic process (GO:0071265) | 2.57466538 |
| 120 | amino acid salvage (GO:0043102) | 2.57466538 |
| 121 | very long-chain fatty acid metabolic process (GO:0000038) | 2.57137161 |
| 122 | adenosine metabolic process (GO:0046085) | 2.56491735 |
| 123 | organelle disassembly (GO:1903008) | 2.55382793 |
| 124 | maturation of 5.8S rRNA (GO:0000460) | 2.53189998 |
| 125 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.52473157 |
| 126 | response to redox state (GO:0051775) | 2.51260833 |
| 127 | keratinocyte development (GO:0003334) | 2.50555161 |
| 128 | protein targeting to mitochondrion (GO:0006626) | 2.50140161 |
| 129 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.50096681 |
| 130 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.50096681 |
| 131 | protein complex biogenesis (GO:0070271) | 2.49081585 |
| 132 | ether metabolic process (GO:0018904) | 2.47522921 |
| 133 | zinc ion transport (GO:0006829) | 2.47316497 |
| 134 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.46980144 |
| 135 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.46920113 |
| 136 | fucose metabolic process (GO:0006004) | 2.46896914 |
| 137 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.46409282 |
| 138 | termination of RNA polymerase III transcription (GO:0006386) | 2.46409282 |
| 139 | GDP-mannose metabolic process (GO:0019673) | 2.45865850 |
| 140 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.45840265 |
| 141 | protein-cofactor linkage (GO:0018065) | 2.45821432 |
| 142 | peroxisome fission (GO:0016559) | 2.45143397 |
| 143 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.45101356 |
| 144 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.43221910 |
| 145 | sterol biosynthetic process (GO:0016126) | 2.43211379 |
| 146 | nucleotide transport (GO:0006862) | 2.42025176 |
| 147 | substantia nigra development (GO:0021762) | 2.41101494 |
| 148 | amyloid precursor protein catabolic process (GO:0042987) | 2.40837751 |
| 149 | presynaptic membrane assembly (GO:0097105) | 2.35613004 |
| 150 | glutathione biosynthetic process (GO:0006750) | 2.34344762 |
| 151 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.32317191 |
| 152 | GPI anchor biosynthetic process (GO:0006506) | 2.31944685 |
| 153 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.31236314 |
| 154 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.31236314 |
| 155 | NADH dehydrogenase complex assembly (GO:0010257) | 2.31236314 |
| 156 | thioester biosynthetic process (GO:0035384) | 2.30811737 |
| 157 | acyl-CoA biosynthetic process (GO:0071616) | 2.30811737 |
| 158 | regulation of beta-amyloid formation (GO:1902003) | 2.30746604 |
| 159 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.29922525 |
| 160 | cellular copper ion homeostasis (GO:0006878) | 2.27903303 |
| 161 | respiratory burst (GO:0045730) | 2.27853698 |
| 162 | toxin metabolic process (GO:0009404) | 2.26374751 |
| 163 | cell redox homeostasis (GO:0045454) | 2.26053562 |
| 164 | cofactor catabolic process (GO:0051187) | 2.25614147 |
| 165 | glycosylceramide metabolic process (GO:0006677) | 2.24833564 |
| 166 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.24818061 |
| 167 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.23665233 |
| 168 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.21542930 |
| 169 | hydrogen ion transmembrane transport (GO:1902600) | 2.20898625 |
| 170 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.20375709 |
| 171 | presynaptic membrane organization (GO:0097090) | 2.19891386 |
| 172 | succinate metabolic process (GO:0006105) | 2.19881674 |
| 173 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.19650102 |
| 174 | proton transport (GO:0015992) | 2.17557856 |
| 175 | intestinal cholesterol absorption (GO:0030299) | 2.16690206 |
| 176 | GPI anchor metabolic process (GO:0006505) | 2.16441608 |
| 177 | peroxisome organization (GO:0007031) | 2.16020537 |
| 178 | hydrogen transport (GO:0006818) | 2.14889975 |
| 179 | dopamine biosynthetic process (GO:0042416) | 2.14843628 |
| 180 | regulation of dopamine metabolic process (GO:0042053) | 2.14675428 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.58022771 |
| 2 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.28556170 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17164973 |
| 4 | ELK1_19687146_ChIP-ChIP_HELA_Human | 3.16056268 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.91619622 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.75007941 |
| 7 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.54632991 |
| 8 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.53697494 |
| 9 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.53391180 |
| 10 | VDR_22108803_ChIP-Seq_LS180_Human | 2.51361418 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.41929786 |
| 12 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.41143348 |
| 13 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.36847137 |
| 14 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.15871537 |
| 15 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.12110889 |
| 16 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.09938090 |
| 17 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.09749032 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.09103616 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.07474766 |
| 20 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.02907919 |
| 21 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 2.00537025 |
| 22 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.98713275 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.95628677 |
| 24 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.95628677 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93621528 |
| 26 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90142936 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.88599815 |
| 28 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.86485515 |
| 29 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.85674553 |
| 30 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.83947367 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82233634 |
| 32 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.80930572 |
| 33 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.78661158 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.76660621 |
| 35 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.72383963 |
| 36 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71988681 |
| 37 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70877093 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.69737633 |
| 39 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.67209337 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65677399 |
| 41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.59847202 |
| 42 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.59796432 |
| 43 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.59188923 |
| 44 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.56417536 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.52927676 |
| 46 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52107464 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.51019019 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.50681647 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.49948823 |
| 50 | * EWS_26573619_Chip-Seq_HEK293_Human | 1.49946771 |
| 51 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.48245395 |
| 52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.46674103 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.46595249 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.45844287 |
| 55 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.45386052 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.44351043 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43101909 |
| 58 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.40726118 |
| 59 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.38286745 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.35757025 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.33995994 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.33118411 |
| 63 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.33041761 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.32513518 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.29968186 |
| 66 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.29178354 |
| 67 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.29178354 |
| 68 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26390817 |
| 69 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24971093 |
| 70 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24690711 |
| 71 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.23841701 |
| 72 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.23263002 |
| 73 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23225231 |
| 74 | FUS_26573619_Chip-Seq_HEK293_Human | 1.22729550 |
| 75 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.22604420 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.22322408 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21666925 |
| 78 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21411024 |
| 79 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20509269 |
| 80 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20459913 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.20451092 |
| 82 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.19730187 |
| 83 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.19360136 |
| 84 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18024519 |
| 85 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17251054 |
| 86 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.16250200 |
| 87 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.16063502 |
| 88 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.15896346 |
| 89 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.15691307 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13743904 |
| 91 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.13667024 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.12910723 |
| 93 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12587105 |
| 94 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.12379448 |
| 95 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.12358598 |
| 96 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11756513 |
| 97 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10833626 |
| 98 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09961662 |
| 99 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.09941853 |
| 100 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.09763137 |
| 101 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.09677785 |
| 102 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09347036 |
| 103 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.09096856 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.08683381 |
| 105 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07786165 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07592803 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06826644 |
| 108 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06752955 |
| 109 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.06488673 |
| 110 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.05196470 |
| 111 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.04490206 |
| 112 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04123235 |
| 113 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.03422989 |
| 114 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.03177156 |
| 115 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.02581563 |
| 116 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02469912 |
| 117 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02154567 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02022502 |
| 119 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.01409195 |
| 120 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.01409195 |
| 121 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.00896228 |
| 122 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.00306783 |
| 123 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.00244328 |
| 124 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.00062031 |
| 125 | CJUN_26792858_Chip-Seq_BT549_Human | 0.99615444 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99030420 |
| 127 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.98990295 |
| 128 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96941818 |
| 129 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.96855081 |
| 130 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96846230 |
| 131 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96515950 |
| 132 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.96146609 |
| 133 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.95234137 |
| 134 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.94595767 |
| 135 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.94399111 |
| 136 | JUN_21703547_ChIP-Seq_K562_Human | 0.93511325 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93310056 |
| 138 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.93293004 |
| 139 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.93181554 |
| 140 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.93142589 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92936772 |
| 142 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92728174 |
| 143 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.91386330 |
| 144 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91093778 |
| 145 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.90844139 |
| 146 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90776762 |
| 147 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.90128278 |
| 148 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89826673 |
| 149 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.88900801 |
| 150 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88862907 |
| 151 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.87923479 |
| 152 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87249952 |
| 153 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.86538357 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86527523 |
| 155 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.86509044 |
| 156 | KDM2B_26808549_Chip-Seq_REH_Human | 0.86269657 |
| 157 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.85838388 |
| 158 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85769277 |
| 159 | AR_20517297_ChIP-Seq_VCAP_Human | 0.85017372 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 3.66445706 |
| 2 | MP0003183_abnormal_peptide_metabolism | 3.39266593 |
| 3 | MP0004043_abnormal_pH_regulation | 3.30942076 |
| 4 | MP0000569_abnormal_digit_pigmentation | 2.85529737 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 2.67129897 |
| 6 | MP0005058_abnormal_lysosome_morphology | 2.66343572 |
| 7 | MP0002938_white_spotting | 2.42632029 |
| 8 | MP0002163_abnormal_gland_morphology | 2.39241998 |
| 9 | MP0009780_abnormal_chondrocyte_physiolo | 2.31852266 |
| 10 | * MP0006054_spinal_hemorrhage | 2.30606204 |
| 11 | MP0000372_irregular_coat_pigmentation | 2.30228629 |
| 12 | MP0005365_abnormal_bile_salt | 2.28702261 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.28315921 |
| 14 | MP0010386_abnormal_urinary_bladder | 2.25840741 |
| 15 | MP0000920_abnormal_myelination | 2.25669516 |
| 16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.18692139 |
| 17 | MP0001666_abnormal_nutrient_absorption | 2.14962378 |
| 18 | MP0003806_abnormal_nucleotide_metabolis | 2.07124214 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 2.05047039 |
| 20 | MP0003786_premature_aging | 2.04443119 |
| 21 | MP0004270_analgesia | 2.03805378 |
| 22 | MP0001529_abnormal_vocalization | 2.01507160 |
| 23 | MP0000013_abnormal_adipose_tissue | 1.98992663 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 1.98305781 |
| 25 | MP0003880_abnormal_central_pattern | 1.92727470 |
| 26 | MP0001986_abnormal_taste_sensitivity | 1.91767899 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.87236390 |
| 28 | MP0005360_urolithiasis | 1.87179474 |
| 29 | MP0008058_abnormal_DNA_repair | 1.84622476 |
| 30 | MP0003718_maternal_effect | 1.81473516 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.77027222 |
| 32 | MP0005408_hypopigmentation | 1.73797949 |
| 33 | MP0005379_endocrine/exocrine_gland_phen | 1.68570864 |
| 34 | MP0005220_abnormal_exocrine_pancreas | 1.66182816 |
| 35 | MP0002693_abnormal_pancreas_physiology | 1.64241826 |
| 36 | MP0005083_abnormal_biliary_tract | 1.63733355 |
| 37 | MP0002837_dystrophic_cardiac_calcinosis | 1.62834239 |
| 38 | MP0005332_abnormal_amino_acid | 1.60870096 |
| 39 | MP0005646_abnormal_pituitary_gland | 1.58411200 |
| 40 | MP0000427_abnormal_hair_cycle | 1.57432397 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.56742841 |
| 42 | MP0006072_abnormal_retinal_apoptosis | 1.55310382 |
| 43 | MP0001905_abnormal_dopamine_level | 1.55075900 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.54153793 |
| 45 | MP0001984_abnormal_olfaction | 1.51367145 |
| 46 | MP0004272_abnormal_basement_membrane | 1.49111561 |
| 47 | MP0002064_seizures | 1.48509278 |
| 48 | MP0002272_abnormal_nervous_system | 1.47876459 |
| 49 | MP0003329_amyloid_beta_deposits | 1.47867827 |
| 50 | MP0002734_abnormal_mechanical_nocicepti | 1.46877196 |
| 51 | MP0004957_abnormal_blastocyst_morpholog | 1.45144501 |
| 52 | MP0002254_reproductive_system_inflammat | 1.44087223 |
| 53 | MP0001944_abnormal_pancreas_morphology | 1.42477902 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.41444405 |
| 55 | MP0001542_abnormal_bone_strength | 1.39323544 |
| 56 | MP0003868_abnormal_feces_composition | 1.38754199 |
| 57 | MP0003011_delayed_dark_adaptation | 1.37705469 |
| 58 | MP0003690_abnormal_glial_cell | 1.37689571 |
| 59 | MP0005636_abnormal_mineral_homeostasis | 1.36227731 |
| 60 | MP0001664_abnormal_digestion | 1.35476757 |
| 61 | MP0002736_abnormal_nociception_after | 1.35473787 |
| 62 | MP0003186_abnormal_redox_activity | 1.30306755 |
| 63 | MP0001764_abnormal_homeostasis | 1.30217056 |
| 64 | MP0001765_abnormal_ion_homeostasis | 1.27446881 |
| 65 | MP0004019_abnormal_vitamin_homeostasis | 1.26996183 |
| 66 | MP0000604_amyloidosis | 1.26261065 |
| 67 | MP0002229_neurodegeneration | 1.25331748 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 1.24564238 |
| 69 | MP0000516_abnormal_urinary_system | 1.24564238 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.23426017 |
| 71 | MP0005395_other_phenotype | 1.22741491 |
| 72 | MP0005165_increased_susceptibility_to | 1.21352070 |
| 73 | MP0000358_abnormal_cell_content/ | 1.21075696 |
| 74 | MP0009046_muscle_twitch | 1.20059074 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.19253202 |
| 76 | MP0004782_abnormal_surfactant_physiolog | 1.18784941 |
| 77 | MP0000647_abnormal_sebaceous_gland | 1.18586941 |
| 78 | MP0006036_abnormal_mitochondrial_physio | 1.18131306 |
| 79 | MP0004142_abnormal_muscle_tone | 1.17775156 |
| 80 | MP0002295_abnormal_pulmonary_circulatio | 1.16021101 |
| 81 | MP0003634_abnormal_glial_cell | 1.14261100 |
| 82 | MP0000230_abnormal_systemic_arterial | 1.14213188 |
| 83 | MP0001970_abnormal_pain_threshold | 1.14008955 |
| 84 | MP0002102_abnormal_ear_morphology | 1.13284622 |
| 85 | MP0005535_abnormal_body_temperature | 1.13249309 |
| 86 | MP0003724_increased_susceptibility_to | 1.13041231 |
| 87 | MP0004264_abnormal_extraembryonic_tissu | 1.10614287 |
| 88 | MP0002733_abnormal_thermal_nociception | 1.08872740 |
| 89 | MP0005174_abnormal_tail_pigmentation | 1.08657658 |
| 90 | MP0004147_increased_porphyrin_level | 1.08275805 |
| 91 | MP0002735_abnormal_chemical_nociception | 1.08029690 |
| 92 | MP0004215_abnormal_myocardial_fiber | 1.07809355 |
| 93 | MP0009745_abnormal_behavioral_response | 1.07443482 |
| 94 | MP0002078_abnormal_glucose_homeostasis | 1.06861263 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 1.05395953 |
| 96 | MP0001968_abnormal_touch/_nociception | 1.04577351 |
| 97 | MP0001756_abnormal_urination | 1.03789735 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01571287 |
| 99 | MP0008260_abnormal_autophagy | 1.01459532 |
| 100 | MP0001243_abnormal_dermal_layer | 1.00941519 |
| 101 | MP0002118_abnormal_lipid_homeostasis | 1.00703698 |
| 102 | MP0001486_abnormal_startle_reflex | 1.00669033 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.99878066 |
| 104 | MP0003950_abnormal_plasma_membrane | 0.98553420 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.98165612 |
| 106 | MP0002090_abnormal_vision | 0.97438076 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.96949486 |
| 108 | MP0009697_abnormal_copulation | 0.96514454 |
| 109 | MP0000613_abnormal_salivary_gland | 0.96459987 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.95741362 |
| 111 | MP0005551_abnormal_eye_electrophysiolog | 0.95576918 |
| 112 | MP0010094_abnormal_chromosome_stability | 0.95326461 |
| 113 | MP0005310_abnormal_salivary_gland | 0.94844368 |
| 114 | MP0002282_abnormal_trachea_morphology | 0.94355228 |
| 115 | MP0008004_abnormal_stomach_pH | 0.94288837 |
| 116 | MP0002138_abnormal_hepatobiliary_system | 0.94066314 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.92929180 |
| 118 | MP0002572_abnormal_emotion/affect_behav | 0.92770368 |
| 119 | * MP0003633_abnormal_nervous_system | 0.91617618 |
| 120 | MP0005253_abnormal_eye_physiology | 0.90606390 |
| 121 | MP0010352_gastrointestinal_tract_polyps | 0.90384291 |
| 122 | MP0005164_abnormal_response_to | 0.90281635 |
| 123 | MP0008932_abnormal_embryonic_tissue | 0.89842926 |
| 124 | MP0000681_abnormal_thyroid_gland | 0.87547663 |
| 125 | MP0003252_abnormal_bile_duct | 0.86664777 |
| 126 | MP0002234_abnormal_pharynx_morphology | 0.86574605 |
| 127 | MP0006276_abnormal_autonomic_nervous | 0.85611180 |
| 128 | MP0002877_abnormal_melanocyte_morpholog | 0.85432753 |
| 129 | MP0002177_abnormal_outer_ear | 0.84609255 |
| 130 | MP0003283_abnormal_digestive_organ | 0.84120914 |
| 131 | MP0000749_muscle_degeneration | 0.84025097 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.83839076 |
| 133 | MP0003941_abnormal_skin_development | 0.83795802 |
| 134 | MP0010329_abnormal_lipoprotein_level | 0.83541126 |
| 135 | MP0004885_abnormal_endolymph | 0.83304135 |
| 136 | MP0002419_abnormal_innate_immunity | 0.83236184 |
| 137 | MP0002168_other_aberrant_phenotype | 0.82187346 |
| 138 | MP0010030_abnormal_orbit_morphology | 0.82151621 |
| 139 | MP0005319_abnormal_enzyme/_coenzyme | 0.82008273 |
| 140 | MP0008877_abnormal_DNA_methylation | 0.81198143 |
| 141 | MP0001533_abnormal_skeleton_physiology | 0.80943293 |
| 142 | MP0001440_abnormal_grooming_behavior | 0.80782275 |
| 143 | MP0003075_altered_response_to | 0.80729725 |
| 144 | MP0000639_abnormal_adrenal_gland | 0.80481888 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.80074172 |
| 146 | MP0006082_CNS_inflammation | 0.79277686 |
| 147 | MP0002063_abnormal_learning/memory/cond | 0.78882535 |
| 148 | MP0003959_abnormal_lean_body | 0.78768713 |
| 149 | MP0010678_abnormal_skin_adnexa | 0.77874545 |
| 150 | MP0001324_abnormal_eye_pigmentation | 0.75328617 |
| 151 | MP0002060_abnormal_skin_morphology | 0.73070269 |
| 152 | MP0005410_abnormal_fertilization | 0.68591588 |
| 153 | MP0005376_homeostasis/metabolism_phenot | 0.68480134 |
| 154 | MP0005330_cardiomyopathy | 0.68068011 |
| 155 | MP0001881_abnormal_mammary_gland | 0.66514947 |
| 156 | MP0003137_abnormal_impulse_conducting | 0.65579775 |
| 157 | MP0002233_abnormal_nose_morphology | 0.65482010 |
| 158 | MP0002160_abnormal_reproductive_system | 0.65425507 |
| 159 | MP0000538_abnormal_urinary_bladder | 0.64804603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 3.87137913 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.67033045 |
| 3 | Acute encephalopathy (HP:0006846) | 3.57764697 |
| 4 | Pheochromocytoma (HP:0002666) | 3.53772089 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.47958424 |
| 6 | Neuroendocrine neoplasm (HP:0100634) | 3.43638745 |
| 7 | Methylmalonic acidemia (HP:0002912) | 3.18976781 |
| 8 | Progressive macrocephaly (HP:0004481) | 3.18055560 |
| 9 | Symptomatic seizures (HP:0011145) | 3.16749709 |
| 10 | Increased hepatocellular lipid droplets (HP:0006565) | 3.16470837 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 3.16237219 |
| 12 | Abnormality of glycolysis (HP:0004366) | 3.08840217 |
| 13 | Increased serum pyruvate (HP:0003542) | 3.08840217 |
| 14 | Hypoglycemic seizures (HP:0002173) | 3.08132953 |
| 15 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.04487889 |
| 16 | Mitochondrial inheritance (HP:0001427) | 3.03914402 |
| 17 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.00477895 |
| 18 | Hypoglycemic coma (HP:0001325) | 3.00421063 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 2.97139512 |
| 20 | Ketoacidosis (HP:0001993) | 2.90353104 |
| 21 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.87167800 |
| 22 | Neurofibrillary tangles (HP:0002185) | 2.79058151 |
| 23 | Lipid accumulation in hepatocytes (HP:0006561) | 2.76476338 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.75552658 |
| 25 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.75552658 |
| 26 | Autoamputation (HP:0001218) | 2.74483090 |
| 27 | Hepatic necrosis (HP:0002605) | 2.70689402 |
| 28 | Exertional dyspnea (HP:0002875) | 2.68254811 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.65935658 |
| 30 | Abnormality of vitamin B metabolism (HP:0004340) | 2.62597759 |
| 31 | Hepatocellular necrosis (HP:0001404) | 2.61137496 |
| 32 | Increased CSF lactate (HP:0002490) | 2.57052500 |
| 33 | Lethargy (HP:0001254) | 2.56523845 |
| 34 | Abnormality of the anterior horn cell (HP:0006802) | 2.56067225 |
| 35 | Degeneration of anterior horn cells (HP:0002398) | 2.56067225 |
| 36 | Congenital, generalized hypertrichosis (HP:0004540) | 2.52613342 |
| 37 | Cerebral edema (HP:0002181) | 2.52197359 |
| 38 | Gout (HP:0001997) | 2.51230723 |
| 39 | Increased serum lactate (HP:0002151) | 2.50340194 |
| 40 | Intrahepatic cholestasis (HP:0001406) | 2.44719000 |
| 41 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.43437043 |
| 42 | Dysostosis multiplex (HP:0000943) | 2.43402853 |
| 43 | Palpitations (HP:0001962) | 2.41156514 |
| 44 | Parakeratosis (HP:0001036) | 2.40421618 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.37424041 |
| 46 | Exercise intolerance (HP:0003546) | 2.35158126 |
| 47 | Generalized aminoaciduria (HP:0002909) | 2.35076346 |
| 48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.34172454 |
| 49 | Amniotic constriction ring (HP:0009775) | 2.33643834 |
| 50 | Abnormality of placental membranes (HP:0011409) | 2.33643834 |
| 51 | Hypothermia (HP:0002045) | 2.31569655 |
| 52 | Fat malabsorption (HP:0002630) | 2.29198089 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.29021459 |
| 54 | Delayed gross motor development (HP:0002194) | 2.24749030 |
| 55 | Retinal dysplasia (HP:0007973) | 2.24452888 |
| 56 | Protuberant abdomen (HP:0001538) | 2.22384502 |
| 57 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.20206372 |
| 58 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.20206372 |
| 59 | Abnormal protein glycosylation (HP:0012346) | 2.20206372 |
| 60 | Abnormal glycosylation (HP:0012345) | 2.20206372 |
| 61 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.19801079 |
| 62 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.19801079 |
| 63 | Progressive neurologic deterioration (HP:0002344) | 2.19762929 |
| 64 | Abnormality of the intrinsic pathway (HP:0010989) | 2.19481550 |
| 65 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.19213308 |
| 66 | Leukodystrophy (HP:0002415) | 2.18968941 |
| 67 | Hyperventilation (HP:0002883) | 2.18931486 |
| 68 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.17703578 |
| 69 | Cerebral hemorrhage (HP:0001342) | 2.17394777 |
| 70 | Adrenal hypoplasia (HP:0000835) | 2.16253238 |
| 71 | Pancreatic fibrosis (HP:0100732) | 2.15403251 |
| 72 | Albinism (HP:0001022) | 2.12102563 |
| 73 | X-linked dominant inheritance (HP:0001423) | 2.11386102 |
| 74 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.11041108 |
| 75 | Steatorrhea (HP:0002570) | 2.10713493 |
| 76 | CNS demyelination (HP:0007305) | 2.10575780 |
| 77 | Ketosis (HP:0001946) | 2.09766064 |
| 78 | Diminished movement (HP:0002374) | 2.08311019 |
| 79 | Type I transferrin isoform profile (HP:0003642) | 2.07246872 |
| 80 | Medial flaring of the eyebrow (HP:0010747) | 2.05607327 |
| 81 | Akinesia (HP:0002304) | 2.05218371 |
| 82 | Disproportionate short-trunk short stature (HP:0003521) | 2.05166711 |
| 83 | Vascular calcification (HP:0004934) | 2.05117436 |
| 84 | Hypokinesia (HP:0002375) | 2.05008883 |
| 85 | Respiratory failure (HP:0002878) | 2.04454647 |
| 86 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.04001979 |
| 87 | Pancreatic cysts (HP:0001737) | 2.03558581 |
| 88 | Increased circulating renin level (HP:0000848) | 2.03497754 |
| 89 | Intestinal atresia (HP:0011100) | 2.03085700 |
| 90 | Tongue fasciculations (HP:0001308) | 2.02847389 |
| 91 | Epileptiform EEG discharges (HP:0011182) | 2.02550248 |
| 92 | Proximal tubulopathy (HP:0000114) | 2.02453478 |
| 93 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.02145663 |
| 94 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.02145663 |
| 95 | Abnormality of vitamin metabolism (HP:0100508) | 2.02036541 |
| 96 | Hypomagnesemia (HP:0002917) | 2.01629762 |
| 97 | Hyperglycemia (HP:0003074) | 2.01621894 |
| 98 | True hermaphroditism (HP:0010459) | 1.99565465 |
| 99 | Cardiovascular calcification (HP:0011915) | 1.99135111 |
| 100 | Hyperactive renin-angiotensin system (HP:0000841) | 1.98137290 |
| 101 | Renal Fanconi syndrome (HP:0001994) | 1.97991229 |
| 102 | Lactic acidosis (HP:0003128) | 1.95842261 |
| 103 | Renal cortical cysts (HP:0000803) | 1.94354417 |
| 104 | Glycosuria (HP:0003076) | 1.94346688 |
| 105 | Abnormality of urine glucose concentration (HP:0011016) | 1.94346688 |
| 106 | Nausea (HP:0002018) | 1.94307175 |
| 107 | Abnormality of alanine metabolism (HP:0010916) | 1.94125869 |
| 108 | Hyperalaninemia (HP:0003348) | 1.94125869 |
| 109 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94125869 |
| 110 | Acute hepatic failure (HP:0006554) | 1.93840510 |
| 111 | Congenital primary aphakia (HP:0007707) | 1.92976049 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 1.92810607 |
| 113 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.92764372 |
| 114 | Mucopolysacchariduria (HP:0008155) | 1.92465892 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.92465892 |
| 116 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91828202 |
| 117 | Hypokalemic alkalosis (HP:0001949) | 1.91025370 |
| 118 | Abnormality of renal resorption (HP:0011038) | 1.90752853 |
| 119 | Type II lissencephaly (HP:0007260) | 1.90283890 |
| 120 | Cerebral inclusion bodies (HP:0100314) | 1.89321604 |
| 121 | Conjunctival hamartoma (HP:0100780) | 1.89150903 |
| 122 | Hypsarrhythmia (HP:0002521) | 1.87302021 |
| 123 | Large for gestational age (HP:0001520) | 1.87135284 |
| 124 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86878985 |
| 125 | Spastic paraparesis (HP:0002313) | 1.84596036 |
| 126 | Gait imbalance (HP:0002141) | 1.84245144 |
| 127 | Poor head control (HP:0002421) | 1.83978551 |
| 128 | Methylmalonic aciduria (HP:0012120) | 1.83735684 |
| 129 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.82582669 |
| 130 | Nephrogenic diabetes insipidus (HP:0009806) | 1.82526009 |
| 131 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82459596 |
| 132 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82459596 |
| 133 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82459596 |
| 134 | Prolonged partial thromboplastin time (HP:0003645) | 1.81209407 |
| 135 | Atonic seizures (HP:0010819) | 1.80927847 |
| 136 | Sensory axonal neuropathy (HP:0003390) | 1.78623522 |
| 137 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.78326549 |
| 138 | Hypoplasia of the fovea (HP:0007750) | 1.78326549 |
| 139 | Abnormality of serum amino acid levels (HP:0003112) | 1.77486448 |
| 140 | Optic disc pallor (HP:0000543) | 1.76795599 |
| 141 | Molar tooth sign on MRI (HP:0002419) | 1.75989956 |
| 142 | Abnormality of midbrain morphology (HP:0002418) | 1.75989956 |
| 143 | Abnormality of purine metabolism (HP:0004352) | 1.75021294 |
| 144 | Bifid tongue (HP:0010297) | 1.74999899 |
| 145 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.74016763 |
| 146 | Epileptic encephalopathy (HP:0200134) | 1.73508503 |
| 147 | Epiphyseal stippling (HP:0010655) | 1.73030041 |
| 148 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.71348960 |
| 149 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.70663869 |
| 150 | Increased intramyocellular lipid droplets (HP:0012240) | 1.70663078 |
| 151 | Late onset (HP:0003584) | 1.70474249 |
| 152 | 3-Methylglutaconic aciduria (HP:0003535) | 1.69750485 |
| 153 | Abnormality of magnesium homeostasis (HP:0004921) | 1.69682179 |
| 154 | Orthostatic hypotension (HP:0001278) | 1.68794422 |
| 155 | Abnormality of renin-angiotensin system (HP:0000847) | 1.68447121 |
| 156 | Hypobetalipoproteinemia (HP:0003563) | 1.68257291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK1 | 3.15242503 |
| 2 | TRIM28 | 3.08951313 |
| 3 | FRK | 3.06733505 |
| 4 | CASK | 3.00478919 |
| 5 | BUB1 | 2.89029133 |
| 6 | OXSR1 | 2.87179326 |
| 7 | STK39 | 2.75651761 |
| 8 | INSRR | 2.65098762 |
| 9 | MST4 | 2.56334394 |
| 10 | WNK4 | 2.54303623 |
| 11 | MAP3K12 | 2.48298928 |
| 12 | STK16 | 2.42545094 |
| 13 | NEK1 | 2.28640248 |
| 14 | MAP4K2 | 2.27290262 |
| 15 | PIK3CG | 2.10916139 |
| 16 | ACVR1B | 2.04636497 |
| 17 | BCR | 2.03546165 |
| 18 | TAOK3 | 2.03364504 |
| 19 | ARAF | 2.02954782 |
| 20 | VRK2 | 1.96637816 |
| 21 | PBK | 1.92079873 |
| 22 | MAPKAPK5 | 1.77159977 |
| 23 | PLK3 | 1.74358126 |
| 24 | BMPR2 | 1.71915248 |
| 25 | MAPK15 | 1.66645802 |
| 26 | WNK3 | 1.66454903 |
| 27 | BMPR1B | 1.61656836 |
| 28 | SIK3 | 1.59625810 |
| 29 | LIMK1 | 1.49960492 |
| 30 | AKT3 | 1.49958711 |
| 31 | RIPK4 | 1.49050738 |
| 32 | BRSK2 | 1.42988224 |
| 33 | EIF2AK3 | 1.38455925 |
| 34 | BCKDK | 1.37622072 |
| 35 | CAMKK2 | 1.36825135 |
| 36 | PRPF4B | 1.34412488 |
| 37 | CAMK2B | 1.32522857 |
| 38 | NME1 | 1.31494478 |
| 39 | ZAK | 1.29965166 |
| 40 | ERN1 | 1.29707313 |
| 41 | MAP3K2 | 1.29592299 |
| 42 | ERBB4 | 1.29085536 |
| 43 | STK38L | 1.23385939 |
| 44 | SRPK1 | 1.22929752 |
| 45 | NME2 | 1.19530850 |
| 46 | CAMK2D | 1.16688648 |
| 47 | MAP2K7 | 1.14765285 |
| 48 | WEE1 | 1.14556424 |
| 49 | CDK19 | 1.14321320 |
| 50 | GRK1 | 1.13247455 |
| 51 | STK3 | 1.12606429 |
| 52 | PRKCE | 1.12226186 |
| 53 | MKNK2 | 1.11595787 |
| 54 | MET | 1.09293667 |
| 55 | PLK2 | 1.08561931 |
| 56 | PAK4 | 1.08110478 |
| 57 | MYLK | 1.08003204 |
| 58 | BRAF | 1.05933477 |
| 59 | EPHB1 | 0.98829793 |
| 60 | NTRK1 | 0.98500805 |
| 61 | WNK1 | 0.98354523 |
| 62 | ADRBK2 | 0.97906526 |
| 63 | PDK2 | 0.97662922 |
| 64 | UHMK1 | 0.97589299 |
| 65 | STK10 | 0.96193565 |
| 66 | MAPKAPK3 | 0.95862574 |
| 67 | MAP3K14 | 0.94438909 |
| 68 | PLK4 | 0.91989782 |
| 69 | CAMK2G | 0.91730413 |
| 70 | EIF2AK2 | 0.89226525 |
| 71 | PAK3 | 0.87575600 |
| 72 | LMTK2 | 0.86286253 |
| 73 | SGK223 | 0.85830569 |
| 74 | SGK494 | 0.85830569 |
| 75 | EPHA2 | 0.84674022 |
| 76 | GRK7 | 0.83861668 |
| 77 | TLK1 | 0.83506164 |
| 78 | ERBB3 | 0.83439233 |
| 79 | CAMK2A | 0.82535896 |
| 80 | TTK | 0.81007369 |
| 81 | CSNK1G3 | 0.80213264 |
| 82 | PNCK | 0.79555023 |
| 83 | PIM2 | 0.79336688 |
| 84 | MKNK1 | 0.78900187 |
| 85 | NTRK3 | 0.78820169 |
| 86 | NUAK1 | 0.78104618 |
| 87 | PRKCQ | 0.77355045 |
| 88 | HIPK2 | 0.76481067 |
| 89 | YES1 | 0.75645857 |
| 90 | TRPM7 | 0.72310048 |
| 91 | PLK1 | 0.70671518 |
| 92 | ILK | 0.69103816 |
| 93 | EPHA3 | 0.68849410 |
| 94 | PHKG2 | 0.68837083 |
| 95 | PHKG1 | 0.68837083 |
| 96 | TNIK | 0.67849465 |
| 97 | PRKCI | 0.65964098 |
| 98 | GRK5 | 0.65365253 |
| 99 | PASK | 0.65333209 |
| 100 | NEK6 | 0.64817729 |
| 101 | MST1R | 0.64104063 |
| 102 | STK24 | 0.63722773 |
| 103 | TYK2 | 0.63480118 |
| 104 | FGFR1 | 0.63315054 |
| 105 | DAPK1 | 0.63151290 |
| 106 | IRAK1 | 0.61754774 |
| 107 | IRAK4 | 0.57417007 |
| 108 | VRK1 | 0.56507884 |
| 109 | TESK2 | 0.56060101 |
| 110 | BRSK1 | 0.56038320 |
| 111 | MAP3K1 | 0.55331886 |
| 112 | TEC | 0.54734041 |
| 113 | CSNK1A1L | 0.54157651 |
| 114 | FGFR2 | 0.53551674 |
| 115 | NEK9 | 0.53476092 |
| 116 | ROCK2 | 0.52838818 |
| 117 | TGFBR2 | 0.52409242 |
| 118 | PRKG2 | 0.52385852 |
| 119 | CSNK1G2 | 0.52156898 |
| 120 | TESK1 | 0.52028391 |
| 121 | MAPK13 | 0.51528240 |
| 122 | MAP3K4 | 0.50763616 |
| 123 | MAP2K2 | 0.49413248 |
| 124 | CCNB1 | 0.48703783 |
| 125 | CDK5 | 0.48234851 |
| 126 | EPHA4 | 0.47881612 |
| 127 | ROCK1 | 0.47766762 |
| 128 | BLK | 0.47169048 |
| 129 | PRKCG | 0.46185667 |
| 130 | DYRK1A | 0.45530746 |
| 131 | MAP2K1 | 0.45433092 |
| 132 | TAF1 | 0.44627201 |
| 133 | CSNK1A1 | 0.44449944 |
| 134 | MAP3K13 | 0.43934884 |
| 135 | CSNK2A1 | 0.43757366 |
| 136 | ADRBK1 | 0.43412740 |
| 137 | TIE1 | 0.42538509 |
| 138 | ABL2 | 0.41552279 |
| 139 | PKN1 | 0.41339095 |
| 140 | AURKB | 0.40682681 |
| 141 | FER | 0.39773511 |
| 142 | TSSK6 | 0.39560328 |
| 143 | PTK2B | 0.38605957 |
| 144 | MAP2K6 | 0.38140661 |
| 145 | CSNK1G1 | 0.36849606 |
| 146 | PRKCD | 0.36008597 |
| 147 | PRKACA | 0.35854411 |
| 148 | PRKCH | 0.35779185 |
| 149 | CSNK2A2 | 0.34716045 |
| 150 | STK4 | 0.27820912 |
| 151 | SCYL2 | 0.27102234 |
| 152 | JAK1 | 0.26181037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 4.98210129 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.80545408 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.35890927 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.08169662 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.79106780 |
| 6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.75185506 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.67102803 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.36568620 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.03723818 |
| 10 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.96236944 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 1.86343811 |
| 12 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.83090379 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82745131 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.80029540 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72242645 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.61542118 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.60407160 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.60181892 |
| 19 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.59399056 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58418345 |
| 21 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.55964642 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.54776965 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.54225501 |
| 24 | Phagosome_Homo sapiens_hsa04145 | 1.49805563 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.46803750 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.45104679 |
| 27 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.44475008 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.43010691 |
| 29 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.42110772 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35005213 |
| 31 | Other glycan degradation_Homo sapiens_hsa00511 | 1.33750577 |
| 32 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32097702 |
| 33 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30329451 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.26500442 |
| 35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.25958346 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.24527933 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21595910 |
| 38 | Basal transcription factors_Homo sapiens_hsa03022 | 1.18850761 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.18092575 |
| 40 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.17066511 |
| 41 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.15789131 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14725280 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.10801856 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.08838595 |
| 45 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06519817 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05426558 |
| 47 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.04369717 |
| 48 | Proteasome_Homo sapiens_hsa03050 | 1.02187978 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01660292 |
| 50 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.00463606 |
| 51 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.99262418 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.98812660 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 0.98289392 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.97103219 |
| 55 | Insulin secretion_Homo sapiens_hsa04911 | 0.95148384 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.86506767 |
| 57 | RNA degradation_Homo sapiens_hsa03018 | 0.85502487 |
| 58 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81957182 |
| 59 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.79947937 |
| 60 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79225704 |
| 61 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.78868315 |
| 62 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.78807138 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.78564369 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77707605 |
| 65 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.77598697 |
| 66 | Carbon metabolism_Homo sapiens_hsa01200 | 0.76306232 |
| 67 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75698817 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75388441 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73642243 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.72373067 |
| 71 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.71221325 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70905734 |
| 73 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.70824187 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70535136 |
| 75 | Nicotine addiction_Homo sapiens_hsa05033 | 0.70394727 |
| 76 | Base excision repair_Homo sapiens_hsa03410 | 0.69992173 |
| 77 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.69816383 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.69731315 |
| 79 | Ribosome_Homo sapiens_hsa03010 | 0.69328407 |
| 80 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.69147411 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69023540 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68950370 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.68277942 |
| 84 | DNA replication_Homo sapiens_hsa03030 | 0.67435572 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.67026707 |
| 86 | RNA transport_Homo sapiens_hsa03013 | 0.65989659 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.65282691 |
| 88 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.64183160 |
| 89 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63819015 |
| 90 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.63566270 |
| 91 | Morphine addiction_Homo sapiens_hsa05032 | 0.62715920 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62278228 |
| 93 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.61756484 |
| 94 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.60875224 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60814804 |
| 96 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60663896 |
| 97 | * Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.59171110 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.58942247 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58639321 |
| 100 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58607827 |
| 101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57682000 |
| 102 | Taste transduction_Homo sapiens_hsa04742 | 0.57610157 |
| 103 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.57601018 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.57364681 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.57235520 |
| 106 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.57081194 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55740220 |
| 108 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55663588 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.54342807 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53035568 |
| 111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51687361 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.51496440 |
| 113 | Spliceosome_Homo sapiens_hsa03040 | 0.49885236 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.49478085 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.48074966 |
| 116 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46946869 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45917419 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45872943 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.44985722 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.43294378 |
| 121 | Circadian entrainment_Homo sapiens_hsa04713 | 0.42634496 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40119121 |
| 123 | Cocaine addiction_Homo sapiens_hsa05030 | 0.39803526 |
| 124 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.38045594 |
| 125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.37962382 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.37215403 |
| 127 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.37164528 |
| 128 | ABC transporters_Homo sapiens_hsa02010 | 0.36408090 |
| 129 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.36287729 |
| 130 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.35055652 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31510465 |
| 132 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31407814 |
| 133 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31083369 |
| 134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.30464173 |
| 135 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29984441 |
| 136 | Prion diseases_Homo sapiens_hsa05020 | 0.29249421 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.27926573 |

